BR0108313A - Pharmaceutical composition for intramuscular injection containing loxoprofen - Google Patents

Pharmaceutical composition for intramuscular injection containing loxoprofen

Info

Publication number
BR0108313A
BR0108313A BR0108313-9A BR0108313A BR0108313A BR 0108313 A BR0108313 A BR 0108313A BR 0108313 A BR0108313 A BR 0108313A BR 0108313 A BR0108313 A BR 0108313A
Authority
BR
Brazil
Prior art keywords
intramuscular injection
pharmaceutical composition
injection containing
containing loxoprofen
loxoprofen
Prior art date
Application number
BR0108313-9A
Other languages
Portuguese (pt)
Inventor
Sung-Tae Lee
Shin Han
Woo-Yle Park
Chul-Kyu Lee
Hye-Seon Kim
Original Assignee
Shin Poong Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Poong Pharmaceutical Co filed Critical Shin Poong Pharmaceutical Co
Publication of BR0108313A publication Critical patent/BR0108313A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA PARA INJEçãO INTRAMUSCULAR CONTENDO LOXOPROFENO". Em anexo é apresentada uma formulação para injeção intramuscular contendo loxoprofeno ou um sal aceitável farmaceuticamente deste, possuindo um efeito analgésico antiinflamatório excelente, como um princípio-ativo."PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTION CONTAINING LOXOPROPHEN". Attached is an intramuscular injection formulation containing loxoprofen or a pharmaceutically acceptable salt thereof, having an excellent anti-inflammatory analgesic effect as an active ingredient.

BR0108313-9A 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen BR0108313A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0076298A KR100405161B1 (en) 2000-12-14 2000-12-14 Pharmaceutical composition for intramuscular injection containing loxoprofen
PCT/KR2001/002161 WO2002047661A1 (en) 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen

Publications (1)

Publication Number Publication Date
BR0108313A true BR0108313A (en) 2003-03-11

Family

ID=36691545

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108313-9A BR0108313A (en) 2000-12-14 2001-12-13 Pharmaceutical composition for intramuscular injection containing loxoprofen

Country Status (12)

Country Link
JP (1) JP2004515526A (en)
KR (1) KR100405161B1 (en)
CN (1) CN1278672C (en)
AP (1) AP1530A (en)
AR (1) AR033596A1 (en)
AU (1) AU2002222750A1 (en)
BR (1) BR0108313A (en)
MX (1) MXPA02007788A (en)
OA (1) OA12175A (en)
RU (1) RU2232572C2 (en)
UA (1) UA76097C2 (en)
WO (1) WO2002047661A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
ES2528669T3 (en) 2003-04-08 2015-02-11 Progenics Pharmaceuticals, Inc. Pharmaceutical formulations containing methylnaltrexone
WO2009031577A1 (en) 2007-09-04 2009-03-12 Meiji Seika Kaisha, Ltd. Injection, injection solution and injection kit preparation
EP2243477A1 (en) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol for parenteral application
JP2011225514A (en) * 2009-10-30 2011-11-10 Kowa Co Pharmaceutical composition containing loxoprofen or salt thereof
EP2926832A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of loxoprofen for topical use
EP2926810A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen
EP2939666A1 (en) 2014-04-29 2015-11-04 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of loxoprofen
EA201692424A1 (en) 2014-06-30 2017-04-28 Сановель Илач Санайи Ве Тиджарет А.Ш. COMBINATION OF LOXOPROPHENE AND AGONIST OF GAMMA-AMINOIL ACID RECEPTORS
WO2016046189A1 (en) 2014-09-24 2016-03-31 Sanovel Ilac Sanayi Ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747535B2 (en) * 1985-11-26 1995-05-24 日東電工株式会社 Anti-inflammatory analgesic patch
JPH10120560A (en) * 1996-08-26 1998-05-12 Sankyo Co Ltd Loxoprofen-containing preparation for external use
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy

Also Published As

Publication number Publication date
RU2232572C2 (en) 2004-07-20
JP2004515526A (en) 2004-05-27
WO2002047661A1 (en) 2002-06-20
CN1400892A (en) 2003-03-05
MXPA02007788A (en) 2002-10-17
UA76097C2 (en) 2006-07-17
KR20020046407A (en) 2002-06-21
KR100405161B1 (en) 2003-11-12
AU2002222750A1 (en) 2002-06-24
AR033596A1 (en) 2003-12-26
AP2002002594A0 (en) 2002-09-30
OA12175A (en) 2006-05-09
AP1530A (en) 2006-01-04
CN1278672C (en) 2006-10-11

Similar Documents

Publication Publication Date Title
BR0107869A (en) Electrogenated pharmaceutical compositions
BR0115382A (en) Controlled release formulations of hydrocodone, method of producing effective analgesia, process of preparing a pharmaceutical form of a controlled release oral solid, controlled release of the oral dosage form and use of the pharmaceutical form
ES2088312T3 (en) CONTROLLED RELEASE FORMULATION CONTAINING TRAMADOL.
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
HN2001000224A (en) IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI - INFLAMMATORY AND ANALGESIC AGENTS.
BRPI0015567B8 (en) compound, pharmaceutical composition, dosage unit form, use of the pharmaceutical composition and method for preparing a pharmaceutical composition
BR9508287A (en) Formulation for inhalation application
ES2185606T3 (en) NEW USE OF A CLASS OF PEPTIDIC COMPOUNDS FOR TREATMENT OF ALLODINIA OR OTHER DIFFERENT TYPES OF CHRONIC OR GHOST PAIN.
ITRM920155A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3-2 (DIMETHYLAMINE) ETHYL-N-METHYL-INDOL-5-METHANAL SULPHONAMIDE, RELATIVE PROCEDURE FOR PREPARATION AND USE OF THE SAME IN TREATMENT OF MAMMALS
ES2295609T3 (en) TIADIAZOLILPIPERAZINA DERIVATIVES USEFUL TO TREAT OR PREVENT A PAIN.
HRP20020088B1 (en) Levodopa/carbidopa/entacapone pharmaceutical preparation
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
BR0012951A (en) Selective retinoid agonists
BR0311414A (en) Therapeutic agent for an overactive bladder
BR0108313A (en) Pharmaceutical composition for intramuscular injection containing loxoprofen
EP1314719A4 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
BRPI0506496A (en) antimicrobial preservatives for obtaining multidose formulation using beta-cyclodextrins for liquid dosage forms
EA200100226A1 (en) TOPICAL, CONTAINING NIMESULIDE PHARMACEUTICAL COMPOSITIONS
ES2195538T3 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF ISOMEROS DEXTRO AND LEVO DE SOTALOL.
BR0013582A (en) Selective retinoid agonists for rar
BR0111051A (en) Pharmaceutical product and daily pharmaceutical dose for administration to a patient, dose regimen providing an anti-androgenic effect and an antiestrogenic effect on a patient, use of a compound and tamoxifen or a pharmaceutically acceptable salt or solvate thereof, and, method for providing an anti-androgenic effect in a patient
DE59914183D1 (en) DISPOSABLE DEVICE FOR A COMPOSITION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
RS50693B (en) Stable pharmaceutical gel of diclofenac sodium
SE0000303D0 (en) Novel compounds
BR9910201A (en) Transdermal therapeutic system for the use of candesartan

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.